Sunagawa M, Kanazawa K, Nouda H
Jpn J Antibiot. 2000 Jul;53(7):479-511.
To date, three carbapenem antibiotics have been introduced for clinical use, and they can be structurally classified into two types. One is a natural type that has the naturally-occurring carbapenem skeleton and a strongly basic (cationic) moiety in the C-2 side chain, like imipenem or panipenem. The other is a new generation carbapenem, meropenem, which has the 1 beta-methyl carbapenem skeleton and a less basic group in the C-2 side chain. It was reported that there were some significant differences among these two types of carbapenems concerning the antimicrobial profile, especially the antipseudomonal activity. Since Pseudomonas aeruginosa was one of the target pathogens of carbapenem antibiotics, these facts prompted us to overview the different mode of action among imipenem, panipenem and meropenem and clarify the structure-activity relationships of carbapenems with regard to the antipseudomonal activities. In this article, we discuss that both the chemical structure and the physicochemical properties of carbapenems greatly influence a variety of antipsedomonal actions including MIC, affinity for PBPs, outer membrane permeability, interaction with various beta-lactamases and multidrug efflux systems etc., and that the cationic center in the C-2 side chain plays an important role in antipseudomonal activities. This review will be helpful in developing new types of antipseudomonal carbapenems and/or new clinical applications of carbapenem antibiotics for treating pseudomonal infection.
迄今为止,已有三种碳青霉烯类抗生素被引入临床使用,它们在结构上可分为两类。一类是天然型,具有天然存在的碳青霉烯骨架以及在C-2侧链上的强碱性(阳离子)部分,如亚胺培南或帕尼培南。另一类是新一代碳青霉烯类抗生素美罗培南,它具有1β-甲基碳青霉烯骨架以及在C-2侧链上碱性较弱的基团。据报道,这两类碳青霉烯类抗生素在抗菌谱方面存在一些显著差异,尤其是抗铜绿假单胞菌活性。由于铜绿假单胞菌是碳青霉烯类抗生素的目标病原体之一,这些事实促使我们概述亚胺培南、帕尼培南和美罗培南之间不同的作用方式,并阐明碳青霉烯类抗生素在抗铜绿假单胞菌活性方面的构效关系。在本文中,我们讨论了碳青霉烯类抗生素的化学结构和物理化学性质对包括最低抑菌浓度(MIC)、对青霉素结合蛋白(PBPs)的亲和力、外膜通透性、与各种β-内酰胺酶和多药外排系统的相互作用等多种抗铜绿假单胞菌作用有很大影响,并且C-2侧链中的阳离子中心在抗铜绿假单胞菌活性中起重要作用。这篇综述将有助于开发新型抗铜绿假单胞菌碳青霉烯类抗生素和/或碳青霉烯类抗生素用于治疗铜绿假单胞菌感染的新临床应用。